nodes	percent_of_prediction	percent_of_DWPC	metapath
Alclometasone—NR3C1—type 2 diabetes mellitus	0.368	0.633	CbGaD
Alclometasone—CYP3A4—type 2 diabetes mellitus	0.213	0.367	CbGaD
Alclometasone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0503	0.152	CbGbCtD
Alclometasone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0449	0.136	CbGbCtD
Alclometasone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.041	0.124	CbGbCtD
Alclometasone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0359	0.109	CbGbCtD
Alclometasone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0324	0.0982	CbGbCtD
Alclometasone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0246	0.0744	CbGbCtD
Alclometasone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0236	0.0713	CbGbCtD
Alclometasone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0236	0.0713	CbGbCtD
Alclometasone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0223	0.0675	CbGbCtD
Alclometasone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0166	0.0503	CbGbCtD
Alclometasone—CYP3A4—Losartan—type 2 diabetes mellitus	0.0152	0.046	CbGbCtD
Alclometasone—Erythema—Tolbutamide—type 2 diabetes mellitus	0.00133	0.0351	CcSEcCtD
Alclometasone—Erythema—Tolazamide—type 2 diabetes mellitus	0.00121	0.0319	CcSEcCtD
Alclometasone—Erythema—Acarbose—type 2 diabetes mellitus	0.00116	0.0307	CcSEcCtD
Alclometasone—Infection—Linagliptin—type 2 diabetes mellitus	0.000969	0.0256	CcSEcCtD
Alclometasone—Erythema—Repaglinide—type 2 diabetes mellitus	0.000968	0.0256	CcSEcCtD
Alclometasone—Prednisone—HSD11B1—type 2 diabetes mellitus	0.000828	0.119	CrCbGaD
Alclometasone—Erythema—Glipizide—type 2 diabetes mellitus	0.000801	0.0212	CcSEcCtD
Alclometasone—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.000766	0.0203	CcSEcCtD
Alclometasone—Rash—Miglitol—type 2 diabetes mellitus	0.000759	0.0201	CcSEcCtD
Alclometasone—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000759	0.0201	CcSEcCtD
Alclometasone—Erythema—Glimepiride—type 2 diabetes mellitus	0.000747	0.0198	CcSEcCtD
Alclometasone—Infection—Rosiglitazone—type 2 diabetes mellitus	0.000742	0.0196	CcSEcCtD
Alclometasone—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.000697	0.0184	CcSEcCtD
Alclometasone—Pruritus—Tolazamide—type 2 diabetes mellitus	0.000697	0.0184	CcSEcCtD
Alclometasone—Rash—Tolbutamide—type 2 diabetes mellitus	0.000683	0.0181	CcSEcCtD
Alclometasone—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000646	0.0171	CcSEcCtD
Alclometasone—Infection—Pioglitazone—type 2 diabetes mellitus	0.000622	0.0164	CcSEcCtD
Alclometasone—Rash—Tolazamide—type 2 diabetes mellitus	0.000621	0.0164	CcSEcCtD
Alclometasone—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000621	0.0164	CcSEcCtD
Alclometasone—Erythema—Glyburide—type 2 diabetes mellitus	0.000616	0.0163	CcSEcCtD
Alclometasone—Rash—Linagliptin—type 2 diabetes mellitus	0.000615	0.0163	CcSEcCtD
Alclometasone—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000614	0.0162	CcSEcCtD
Alclometasone—Infection—Sitagliptin—type 2 diabetes mellitus	0.000604	0.016	CcSEcCtD
Alclometasone—Rash—Acarbose—type 2 diabetes mellitus	0.000597	0.0158	CcSEcCtD
Alclometasone—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000596	0.0158	CcSEcCtD
Alclometasone—Rash—Nateglinide—type 2 diabetes mellitus	0.000576	0.0152	CcSEcCtD
Alclometasone—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000575	0.0152	CcSEcCtD
Alclometasone—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000559	0.0148	CcSEcCtD
Alclometasone—Erythema—Gliclazide—type 2 diabetes mellitus	0.000554	0.0146	CcSEcCtD
Alclometasone—Infection—Bromocriptine—type 2 diabetes mellitus	0.000547	0.0145	CcSEcCtD
Alclometasone—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000528	0.014	CcSEcCtD
Alclometasone—Rash—Repaglinide—type 2 diabetes mellitus	0.000498	0.0132	CcSEcCtD
Alclometasone—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000498	0.0132	CcSEcCtD
Alclometasone—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000471	0.0124	CcSEcCtD
Alclometasone—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00047	0.0124	CcSEcCtD
Alclometasone—Erythema—Metformin—type 2 diabetes mellitus	0.000463	0.0122	CcSEcCtD
Alclometasone—Pruritus—Glipizide—type 2 diabetes mellitus	0.000462	0.0122	CcSEcCtD
Alclometasone—Infection—Gliclazide—type 2 diabetes mellitus	0.000449	0.0119	CcSEcCtD
Alclometasone—Erythema—Irbesartan—type 2 diabetes mellitus	0.000437	0.0116	CcSEcCtD
Alclometasone—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000432	0.0114	CcSEcCtD
Alclometasone—Infection—Valsartan—type 2 diabetes mellitus	0.000412	0.0109	CcSEcCtD
Alclometasone—Rash—Glipizide—type 2 diabetes mellitus	0.000412	0.0109	CcSEcCtD
Alclometasone—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000412	0.0109	CcSEcCtD
Alclometasone—Erythema—Losartan—type 2 diabetes mellitus	0.000411	0.0109	CcSEcCtD
Alclometasone—Infection—Orlistat—type 2 diabetes mellitus	0.000407	0.0108	CcSEcCtD
Alclometasone—Rash—Glimepiride—type 2 diabetes mellitus	0.000385	0.0102	CcSEcCtD
Alclometasone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000384	0.0102	CcSEcCtD
Alclometasone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000383	0.0101	CcSEcCtD
Alclometasone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000383	0.0101	CcSEcCtD
Alclometasone—Infection—Metformin—type 2 diabetes mellitus	0.000375	0.00993	CcSEcCtD
Alclometasone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—type 2 diabetes mellitus	0.000375	0.00859	CbGpPWpGaD
Alclometasone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—type 2 diabetes mellitus	0.000369	0.00845	CbGpPWpGaD
Alclometasone—NR3C1—Transcription factor regulation in adipogenesis—LEP—type 2 diabetes mellitus	0.000367	0.0084	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—RETN—type 2 diabetes mellitus	0.000364	0.00833	CbGpPWpGaD
Alclometasone—CYP3A4—Oxidation by Cytochrome P450—CYB5R4—type 2 diabetes mellitus	0.000357	0.00818	CbGpPWpGaD
Alclometasone—Pruritus—Glyburide—type 2 diabetes mellitus	0.000356	0.00941	CcSEcCtD
Alclometasone—Infection—Irbesartan—type 2 diabetes mellitus	0.000354	0.00937	CcSEcCtD
Alclometasone—NR3C1—Circadian Clock—CPT1A—type 2 diabetes mellitus	0.000354	0.0081	CbGpPWpGaD
Alclometasone—Erythema—Ramipril—type 2 diabetes mellitus	0.000353	0.00932	CcSEcCtD
Alclometasone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—type 2 diabetes mellitus	0.000352	0.00806	CbGpPWpGaD
Alclometasone—Rash—Bromocriptine—type 2 diabetes mellitus	0.000347	0.00917	CcSEcCtD
Alclometasone—NR3C1—Circadian Clock—NAMPT—type 2 diabetes mellitus	0.000347	0.00794	CbGpPWpGaD
Alclometasone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000347	0.00916	CcSEcCtD
Alclometasone—Infection—Losartan—type 2 diabetes mellitus	0.000333	0.00882	CcSEcCtD
Alclometasone—NR3C1—Nuclear Receptors—AR—type 2 diabetes mellitus	0.00033	0.00755	CbGpPWpGaD
Alclometasone—NR3C1—Circadian Clock—F7—type 2 diabetes mellitus	0.000329	0.00753	CbGpPWpGaD
Alclometasone—NR3C1—Transcription factor regulation in adipogenesis—IRS1—type 2 diabetes mellitus	0.000327	0.0075	CbGpPWpGaD
Alclometasone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—type 2 diabetes mellitus	0.00032	0.00732	CbGpPWpGaD
Alclometasone—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00032	0.00845	CcSEcCtD
Alclometasone—CYP3A4—Tryptophan metabolism—AANAT—type 2 diabetes mellitus	0.000319	0.0073	CbGpPWpGaD
Alclometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—type 2 diabetes mellitus	0.000317	0.00726	CbGpPWpGaD
Alclometasone—Rash—Glyburide—type 2 diabetes mellitus	0.000317	0.00839	CcSEcCtD
Alclometasone—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000317	0.00838	CcSEcCtD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.000315	0.0072	CbGpPWpGaD
Alclometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—type 2 diabetes mellitus	0.000313	0.00717	CbGpPWpGaD
Alclometasone—NR3C1—Circadian Clock—SREBF1—type 2 diabetes mellitus	0.000309	0.00708	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—ATF3—type 2 diabetes mellitus	0.000302	0.00691	CbGpPWpGaD
Alclometasone—Pruritus—Valsartan—type 2 diabetes mellitus	0.000294	0.00776	CcSEcCtD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.000292	0.0067	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.000292	0.0067	CbGpPWpGaD
Alclometasone—Pruritus—Orlistat—type 2 diabetes mellitus	0.00029	0.00767	CcSEcCtD
Alclometasone—NR3C1—Adipogenesis—HNF1A—type 2 diabetes mellitus	0.000288	0.00659	CbGpPWpGaD
Alclometasone—Rash—Gliclazide—type 2 diabetes mellitus	0.000285	0.00753	CcSEcCtD
Alclometasone—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000285	0.00752	CcSEcCtD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—type 2 diabetes mellitus	0.000269	0.00615	CbGpPWpGaD
Alclometasone—Pruritus—Metformin—type 2 diabetes mellitus	0.000267	0.00707	CcSEcCtD
Alclometasone—NR3C1—Adipogenesis—MIF—type 2 diabetes mellitus	0.000265	0.00608	CbGpPWpGaD
Alclometasone—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA6—type 2 diabetes mellitus	0.000265	0.00607	CbGpPWpGaD
Alclometasone—Rash—Valsartan—type 2 diabetes mellitus	0.000262	0.00692	CcSEcCtD
Alclometasone—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000261	0.00691	CcSEcCtD
Alclometasone—NR3C1—Nuclear Receptor transcription pathway—AR—type 2 diabetes mellitus	0.00026	0.00596	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—type 2 diabetes mellitus	0.000259	0.00594	CbGpPWpGaD
Alclometasone—Rash—Orlistat—type 2 diabetes mellitus	0.000259	0.00684	CcSEcCtD
Alclometasone—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000258	0.00683	CcSEcCtD
Alclometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—type 2 diabetes mellitus	0.000255	0.00584	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—AR—type 2 diabetes mellitus	0.000253	0.00578	CbGpPWpGaD
Alclometasone—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000252	0.00667	CcSEcCtD
Alclometasone—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—type 2 diabetes mellitus	0.000251	0.00575	CbGpPWpGaD
Alclometasone—NR3C1—Nuclear Receptors—PPARA—type 2 diabetes mellitus	0.00025	0.00572	CbGpPWpGaD
Alclometasone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—type 2 diabetes mellitus	0.000248	0.00569	CbGpPWpGaD
Alclometasone—Prednicarbate—NR3C1—type 2 diabetes mellitus	0.000247	0.0355	CrCbGaD
Alclometasone—Clocortolone—NR3C1—type 2 diabetes mellitus	0.000247	0.0355	CrCbGaD
Alclometasone—NR3C1—AP-1 transcription factor network—TIMP1—type 2 diabetes mellitus	0.000242	0.00553	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—PCK1—type 2 diabetes mellitus	0.000241	0.00552	CbGpPWpGaD
Alclometasone—Rash—Metformin—type 2 diabetes mellitus	0.000238	0.0063	CcSEcCtD
Alclometasone—Dermatitis—Metformin—type 2 diabetes mellitus	0.000238	0.00629	CcSEcCtD
Alclometasone—Pruritus—Losartan—type 2 diabetes mellitus	0.000237	0.00628	CcSEcCtD
Alclometasone—Diflorasone—NR3C1—type 2 diabetes mellitus	0.000234	0.0336	CrCbGaD
Alclometasone—Desonide—NR3C1—type 2 diabetes mellitus	0.000234	0.0336	CrCbGaD
Alclometasone—NR3C1—Circadian Clock—PPARGC1A—type 2 diabetes mellitus	0.000231	0.00529	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—SIRT1—type 2 diabetes mellitus	0.00023	0.00527	CbGpPWpGaD
Alclometasone—Desoximetasone—NR3C1—type 2 diabetes mellitus	0.000228	0.0328	CrCbGaD
Alclometasone—NR3C1—Circadian Clock—AVP—type 2 diabetes mellitus	0.000228	0.00522	CbGpPWpGaD
Alclometasone—CYP3A4—Estrogen metabolism—CYP1A2—type 2 diabetes mellitus	0.000226	0.00518	CbGpPWpGaD
Alclometasone—Loteprednol—NR3C1—type 2 diabetes mellitus	0.000225	0.0324	CrCbGaD
Alclometasone—Rash—Irbesartan—type 2 diabetes mellitus	0.000225	0.00594	CcSEcCtD
Alclometasone—NR3C1—AP-1 transcription factor network—TCF7L2—type 2 diabetes mellitus	0.000225	0.00515	CbGpPWpGaD
Alclometasone—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000225	0.00594	CcSEcCtD
Alclometasone—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—type 2 diabetes mellitus	0.000217	0.00496	CbGpPWpGaD
Alclometasone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—type 2 diabetes mellitus	0.000212	0.00486	CbGpPWpGaD
Alclometasone—Rash—Losartan—type 2 diabetes mellitus	0.000212	0.00559	CcSEcCtD
Alclometasone—Dermatitis—Losartan—type 2 diabetes mellitus	0.000211	0.00559	CcSEcCtD
Alclometasone—CYP3A4—Xenobiotics—CYP2E1—type 2 diabetes mellitus	0.00021	0.00481	CbGpPWpGaD
Alclometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—type 2 diabetes mellitus	0.000208	0.00477	CbGpPWpGaD
Alclometasone—CYP3A4—Xenobiotics—CYP1A2—type 2 diabetes mellitus	0.000208	0.00476	CbGpPWpGaD
Alclometasone—NR3C1—Nuclear Receptors—PPARG—type 2 diabetes mellitus	0.000206	0.00473	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—GJA1—type 2 diabetes mellitus	0.000204	0.00467	CbGpPWpGaD
Alclometasone—Pruritus—Ramipril—type 2 diabetes mellitus	0.000204	0.00538	CcSEcCtD
Alclometasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—type 2 diabetes mellitus	0.000202	0.00463	CbGpPWpGaD
Alclometasone—CYP3A4—Tamoxifen metabolism—CYP2E1—type 2 diabetes mellitus	0.000202	0.00463	CbGpPWpGaD
Alclometasone—CYP3A4—Tamoxifen metabolism—CYP1A2—type 2 diabetes mellitus	0.0002	0.00458	CbGpPWpGaD
Alclometasone—Flurandrenolide—NR3C1—type 2 diabetes mellitus	0.0002	0.0287	CrCbGaD
Alclometasone—NR3C1—Nuclear Receptor transcription pathway—PPARA—type 2 diabetes mellitus	0.000197	0.00452	CbGpPWpGaD
Alclometasone—Flumethasone Pivalate—NR3C1—type 2 diabetes mellitus	0.000196	0.0282	CrCbGaD
Alclometasone—Halobetasol Propionate—NR3C1—type 2 diabetes mellitus	0.000193	0.0278	CrCbGaD
Alclometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—type 2 diabetes mellitus	0.00019	0.00435	CbGpPWpGaD
Alclometasone—NR3C1—Circadian Clock—PPARA—type 2 diabetes mellitus	0.000186	0.00425	CbGpPWpGaD
Alclometasone—Rash—Ramipril—type 2 diabetes mellitus	0.000181	0.0048	CcSEcCtD
Alclometasone—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000181	0.00479	CcSEcCtD
Alclometasone—NR3C1—Circadian Clock—HIF1A—type 2 diabetes mellitus	0.000181	0.00414	CbGpPWpGaD
Alclometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—type 2 diabetes mellitus	0.00018	0.00412	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—type 2 diabetes mellitus	0.00018	0.00412	CbGpPWpGaD
Alclometasone—Budesonide—NR3C1—type 2 diabetes mellitus	0.00018	0.0258	CrCbGaD
Alclometasone—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—type 2 diabetes mellitus	0.000179	0.0041	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—EDN1—type 2 diabetes mellitus	0.000179	0.00409	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—NAMPT—type 2 diabetes mellitus	0.000174	0.00399	CbGpPWpGaD
Alclometasone—CYP3A4—Estrogen metabolism—GSTM1—type 2 diabetes mellitus	0.000173	0.00397	CbGpPWpGaD
Alclometasone—Mometasone—NR3C1—type 2 diabetes mellitus	0.000171	0.0246	CrCbGaD
Alclometasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—type 2 diabetes mellitus	0.00017	0.00389	CbGpPWpGaD
Alclometasone—Rimexolone—NR3C1—type 2 diabetes mellitus	0.000169	0.0243	CrCbGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—type 2 diabetes mellitus	0.000166	0.0038	CbGpPWpGaD
Alclometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—type 2 diabetes mellitus	0.000165	0.00378	CbGpPWpGaD
Alclometasone—NR3C1—Nuclear Receptor transcription pathway—PPARG—type 2 diabetes mellitus	0.000163	0.00374	CbGpPWpGaD
Alclometasone—Beclomethasone—NR3C1—type 2 diabetes mellitus	0.000159	0.0229	CrCbGaD
Alclometasone—NR3C1—Adipogenesis—HMGA1—type 2 diabetes mellitus	0.000158	0.00363	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—SREBF1—type 2 diabetes mellitus	0.000155	0.00356	CbGpPWpGaD
Alclometasone—Fluocinolone Acetonide—NR3C1—type 2 diabetes mellitus	0.000155	0.0222	CrCbGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000154	0.00352	CbGpPWpGaD
Alclometasone—Flunisolide—NR3C1—type 2 diabetes mellitus	0.000151	0.0217	CrCbGaD
Alclometasone—Clobetasol propionate—NR3C1—type 2 diabetes mellitus	0.000151	0.0217	CrCbGaD
Alclometasone—NR3C1—AP-1 transcription factor network—MMP1—type 2 diabetes mellitus	0.00015	0.00344	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.00015	0.00343	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—HIF1A—type 2 diabetes mellitus	0.000149	0.00341	CbGpPWpGaD
Alclometasone—Paramethasone—NR3C1—type 2 diabetes mellitus	0.000149	0.0214	CrCbGaD
Alclometasone—NR3C1—AP-1 transcription factor network—AGT—type 2 diabetes mellitus	0.000148	0.0034	CbGpPWpGaD
Alclometasone—Ciclesonide—NR3C1—type 2 diabetes mellitus	0.000146	0.021	CrCbGaD
Alclometasone—Fluorometholone—NR3C1—type 2 diabetes mellitus	0.000145	0.0209	CrCbGaD
Alclometasone—NR3C1—Adipogenesis—ADIPOQ—type 2 diabetes mellitus	0.000143	0.00327	CbGpPWpGaD
Alclometasone—Methylprednisolone—NR3C1—type 2 diabetes mellitus	0.00014	0.0202	CrCbGaD
Alclometasone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—type 2 diabetes mellitus	0.00014	0.0032	CbGpPWpGaD
Alclometasone—NR3C1—Circadian Clock—SERPINE1—type 2 diabetes mellitus	0.000138	0.00317	CbGpPWpGaD
Alclometasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—type 2 diabetes mellitus	0.000137	0.00315	CbGpPWpGaD
Alclometasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—type 2 diabetes mellitus	0.000137	0.00314	CbGpPWpGaD
Alclometasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—type 2 diabetes mellitus	0.000136	0.00311	CbGpPWpGaD
Alclometasone—Dexamethasone—CYP11A1—type 2 diabetes mellitus	0.000135	0.0194	CrCbGaD
Alclometasone—NR3C1—Adipogenesis—SLC2A4—type 2 diabetes mellitus	0.000135	0.00308	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000134	0.00307	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—type 2 diabetes mellitus	0.000132	0.00303	CbGpPWpGaD
Alclometasone—Clobetasol propionate—CYP1A2—type 2 diabetes mellitus	0.000132	0.019	CrCbGaD
Alclometasone—Hydrocortisone—SHBG—type 2 diabetes mellitus	0.000127	0.0183	CrCbGaD
Alclometasone—NR3C1—AP-1 transcription factor network—CCL2—type 2 diabetes mellitus	0.000122	0.0028	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—IGF2BP2—type 2 diabetes mellitus	0.000122	0.00279	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—type 2 diabetes mellitus	0.00012	0.00275	CbGpPWpGaD
Alclometasone—Triamcinolone—NR3C1—type 2 diabetes mellitus	0.000118	0.017	CrCbGaD
Alclometasone—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	0.000118	0.0027	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—PPARGC1A—type 2 diabetes mellitus	0.000116	0.00266	CbGpPWpGaD
Alclometasone—Dexamethasone—NOS2—type 2 diabetes mellitus	0.000112	0.016	CrCbGaD
Alclometasone—CYP3A4—Tryptophan metabolism—CYP2E1—type 2 diabetes mellitus	0.000108	0.00247	CbGpPWpGaD
Alclometasone—Prednisone—NR3C1—type 2 diabetes mellitus	0.000107	0.0154	CrCbGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000107	0.00246	CbGpPWpGaD
Alclometasone—CYP3A4—Tryptophan metabolism—CYP1A2—type 2 diabetes mellitus	0.000107	0.00244	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—CDKN2A—type 2 diabetes mellitus	0.000107	0.00244	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000106	0.00244	CbGpPWpGaD
Alclometasone—Fluticasone Propionate—NR3C1—type 2 diabetes mellitus	0.000106	0.0152	CrCbGaD
Alclometasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	0.000106	0.00242	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—LPL—type 2 diabetes mellitus	0.000106	0.00242	CbGpPWpGaD
Alclometasone—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	0.000104	0.00239	CbGpPWpGaD
Alclometasone—Budesonide—CYP3A4—type 2 diabetes mellitus	0.000104	0.015	CrCbGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—type 2 diabetes mellitus	0.000101	0.00232	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—SRC—type 2 diabetes mellitus	0.000101	0.0023	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.0001	0.0023	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.0001	0.0023	CbGpPWpGaD
Alclometasone—Prednisolone—NR3C1—type 2 diabetes mellitus	9.9e-05	0.0142	CrCbGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	9.9e-05	0.00227	CbGpPWpGaD
Alclometasone—Betamethasone—NR3C1—type 2 diabetes mellitus	9.7e-05	0.0139	CrCbGaD
Alclometasone—NR3C1—Adipogenesis—FAS—type 2 diabetes mellitus	9.65e-05	0.00221	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	9.52e-05	0.00218	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—PPARA—type 2 diabetes mellitus	9.34e-05	0.00214	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—MAT1A—type 2 diabetes mellitus	9.27e-05	0.00212	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—HIF1A—type 2 diabetes mellitus	9.07e-05	0.00208	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—IRS2—type 2 diabetes mellitus	9.05e-05	0.00207	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—AGT—type 2 diabetes mellitus	9.04e-05	0.00207	CbGpPWpGaD
Alclometasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	9.03e-05	0.00207	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—RELA—type 2 diabetes mellitus	9.03e-05	0.00207	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—LEP—type 2 diabetes mellitus	8.86e-05	0.00203	CbGpPWpGaD
Alclometasone—Flunisolide—CYP3A4—type 2 diabetes mellitus	8.74e-05	0.0126	CrCbGaD
Alclometasone—NR3C1—AP-1 transcription factor network—MMP9—type 2 diabetes mellitus	8.74e-05	0.002	CbGpPWpGaD
Alclometasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	8.73e-05	0.002	CbGpPWpGaD
Alclometasone—CYP3A4—Tryptophan metabolism—CAT—type 2 diabetes mellitus	8.66e-05	0.00198	CbGpPWpGaD
Alclometasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	8.63e-05	0.00198	CbGpPWpGaD
Alclometasone—Paramethasone—CYP3A4—type 2 diabetes mellitus	8.63e-05	0.0124	CrCbGaD
Alclometasone—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	8.61e-05	0.00197	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	8.57e-05	0.00196	CbGpPWpGaD
Alclometasone—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	8.52e-05	0.00195	CbGpPWpGaD
Alclometasone—Ciclesonide—CYP3A4—type 2 diabetes mellitus	8.49e-05	0.0122	CrCbGaD
Alclometasone—Fluorometholone—CYP3A4—type 2 diabetes mellitus	8.42e-05	0.0121	CrCbGaD
Alclometasone—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	8.14e-05	0.0117	CrCbGaD
Alclometasone—NR3C1—Adipogenesis—IRS1—type 2 diabetes mellitus	7.9e-05	0.00181	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	7.84e-05	0.0018	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—PPARG—type 2 diabetes mellitus	7.72e-05	0.00177	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—type 2 diabetes mellitus	7.62e-05	0.00174	CbGpPWpGaD
Alclometasone—Hydrocortisone—NR3C1—type 2 diabetes mellitus	7.57e-05	0.0109	CrCbGaD
Alclometasone—NR3C1—Adipogenesis—INS—type 2 diabetes mellitus	7.57e-05	0.00173	CbGpPWpGaD
Alclometasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	7.47e-05	0.00171	CbGpPWpGaD
Alclometasone—Dexamethasone—ABCC2—type 2 diabetes mellitus	7.4e-05	0.0106	CrCbGaD
Alclometasone—NR3C1—Endoderm Differentiation—TGFB1—type 2 diabetes mellitus	7.37e-05	0.00169	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—IGF1—type 2 diabetes mellitus	7.32e-05	0.00168	CbGpPWpGaD
Alclometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	7.26e-05	0.00166	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—TGFB1—type 2 diabetes mellitus	7.2e-05	0.00165	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	7.08e-05	0.00162	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	7e-05	0.0016	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—SERPINE1—type 2 diabetes mellitus	6.95e-05	0.00159	CbGpPWpGaD
Alclometasone—Triamcinolone—CYP3A4—type 2 diabetes mellitus	6.87e-05	0.00987	CrCbGaD
Alclometasone—Triamcinolone—PTGS2—type 2 diabetes mellitus	6.72e-05	0.00966	CrCbGaD
Alclometasone—NR3C1—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	6.49e-05	0.00149	CbGpPWpGaD
Alclometasone—Prednisone—CYP3A4—type 2 diabetes mellitus	6.23e-05	0.00895	CrCbGaD
Alclometasone—Fluticasone Propionate—CYP3A4—type 2 diabetes mellitus	6.14e-05	0.00882	CrCbGaD
Alclometasone—Prednisolone—CYP3A4—type 2 diabetes mellitus	5.74e-05	0.00825	CrCbGaD
Alclometasone—Dexamethasone—NR3C1—type 2 diabetes mellitus	5.64e-05	0.00811	CrCbGaD
Alclometasone—Betamethasone—CYP3A4—type 2 diabetes mellitus	5.62e-05	0.00808	CrCbGaD
Alclometasone—NR3C1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	5.57e-05	0.00127	CbGpPWpGaD
Alclometasone—Betamethasone—PTGS2—type 2 diabetes mellitus	5.51e-05	0.00791	CrCbGaD
Alclometasone—Prednisone—ALB—type 2 diabetes mellitus	5.43e-05	0.00781	CrCbGaD
Alclometasone—NR3C1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	5.43e-05	0.00124	CbGpPWpGaD
Alclometasone—Dexamethasone—CYP2E1—type 2 diabetes mellitus	5.19e-05	0.00746	CrCbGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	4.87e-05	0.00112	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	4.82e-05	0.0011	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	4.78e-05	0.00109	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	4.7e-05	0.00108	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	4.58e-05	0.00105	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	4.55e-05	0.00104	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	4.55e-05	0.00104	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	4.5e-05	0.00103	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	4.49e-05	0.00103	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	4.45e-05	0.00102	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	4.41e-05	0.00101	CbGpPWpGaD
Alclometasone—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	4.39e-05	0.00631	CrCbGaD
Alclometasone—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	4.39e-05	0.001	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	4.14e-05	0.000949	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	4.13e-05	0.000946	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	4.1e-05	0.000938	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	3.76e-05	0.000861	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	3.72e-05	0.000851	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	3.71e-05	0.000849	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	3.67e-05	0.000839	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	3.54e-05	0.000811	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	3.41e-05	0.000781	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	3.31e-05	0.000757	CbGpPWpGaD
Alclometasone—Dexamethasone—CYP3A4—type 2 diabetes mellitus	3.27e-05	0.0047	CrCbGaD
Alclometasone—Dexamethasone—PTGS2—type 2 diabetes mellitus	3.2e-05	0.0046	CrCbGaD
Alclometasone—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	3.12e-05	0.000715	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	2.86e-05	0.000654	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.85e-05	0.000652	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	2.82e-05	0.000645	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.81e-05	0.000643	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	2.73e-05	0.000625	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	2.73e-05	0.000625	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	2.68e-05	0.000614	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	2.54e-05	0.000581	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	2.32e-05	0.000532	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	2.17e-05	0.000497	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	2.17e-05	0.000496	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	2e-05	0.000457	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	1.97e-05	0.000452	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.9e-05	0.000435	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.9e-05	0.000435	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.8e-05	0.000412	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.8e-05	0.000412	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.74e-05	0.000399	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.72e-05	0.000393	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	1.64e-05	0.000376	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.58e-05	0.000363	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.58e-05	0.000363	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.53e-05	0.000351	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.53e-05	0.000351	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.53e-05	0.000351	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.53e-05	0.000351	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.53e-05	0.000351	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.48e-05	0.000339	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.4e-05	0.000321	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.4e-05	0.000321	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.36e-05	0.000312	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	1.36e-05	0.000311	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.3e-05	0.000298	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.3e-05	0.000298	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.3e-05	0.000298	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.25e-05	0.000286	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.25e-05	0.000286	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.22e-05	0.00028	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.2e-05	0.000275	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.2e-05	0.000275	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.18e-05	0.00027	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.16e-05	0.000266	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.16e-05	0.000266	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.16e-05	0.000266	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.09e-05	0.00025	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.02e-05	0.000234	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	9.86e-06	0.000226	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	9.86e-06	0.000226	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	9.86e-06	0.000226	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	9.86e-06	0.000226	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	9.46e-06	0.000217	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	8.79e-06	0.000201	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	8.21e-06	0.000188	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	8.04e-06	0.000184	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	8.04e-06	0.000184	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	7.89e-06	0.000181	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	7.84e-06	0.000179	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	7.84e-06	0.000179	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	7.84e-06	0.000179	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	7.79e-06	0.000178	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	7.65e-06	0.000175	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	7.56e-06	0.000173	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	7.03e-06	0.000161	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	7.03e-06	0.000161	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	7.03e-06	0.000161	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	6.9e-06	0.000158	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	6.84e-06	0.000157	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	6.69e-06	0.000153	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	6.43e-06	0.000147	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	6.36e-06	0.000146	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	6.36e-06	0.000146	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	6.09e-06	0.00014	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	6.09e-06	0.00014	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	5.36e-06	0.000123	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.25e-06	0.00012	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.25e-06	0.00012	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.23e-06	0.00012	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.16e-06	0.000118	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	5.01e-06	0.000115	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.87e-06	0.000112	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.78e-06	0.000109	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.68e-06	0.000107	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.67e-06	0.000107	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.54e-06	0.000104	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.49e-06	0.000103	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.31e-06	9.86e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.22e-06	9.67e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	4.09e-06	9.37e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	4.02e-06	9.21e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	4.01e-06	9.18e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.96e-06	9.07e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.49e-06	7.99e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.42e-06	7.84e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.14e-06	7.19e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3e-06	6.88e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3e-06	6.88e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.75e-06	6.29e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.38e-06	3.16e-05	CbGpPWpGaD
